The Role of Oncolytic Viruses in the Treatment of Melanoma
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2018-08-25 / Curr Oncol Rep 2018 08;20(10):80Further clinical advancement of dendritic cell vaccination against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-08-23 / Ann Res Hosp 2018 Aug;2Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-22 / Cancer Immunol. Immunother. 2018 Nov;67(11):1777-1788Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy
/in Checkpoint-Inhibitors, International Publications /von 2018-08-22 / Expert Rev Vaccines 2018 08;17(8):697-705Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-08-16 / Int J Mol Sci 2018 Aug;19(8)Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-07 / Sci Rep 2018 Aug;8(1):11800Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-08-05 / BMJ Open 2018 08;8(8):e021701Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2018-08-01 / Am J Cancer Res 2018;8(8):1514-1527Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
/in Brain Tumors in Children, International Publications, IOZK Veröffentlichungen /von 2018-08-01 / Lancet Oncol 2018 08;19(8):e419-e428
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution